Scholarlink

Background <p>Skin cancer is among the most common malignancies in Germany. In the context of demographic change, a&#xa0;detailed assessment of incidence, mortality, and survival is essential.</p> Objective <p>This article describes recent epidemiological indicators of malignant melanoma and non-melanoma skin cancer based on pooled population-based cancer registry data.</p> Materials and methods <p>Pooled data from federal state cancer registries were analyzed. Crude and age-standardized incidence and mortality rates, absolute case numbers, and 5‑year survival (Ederer&#xa0;II) were calculated. National estimates were derived by applying age- and sex-specific pooled rates to the German population.</p> Results <p>For melanoma, an average of around 28,000 new cases per year in Germany was calculated for the period 2020–2023. Age-standardized rates changed moderately overall but increased markedly in older age groups, while trends below age&#xa0;50 were stable or declining. Relative 5‑year survival exceeded 95% but decreased with age. Due to its high incidence, non-melanoma skin cancer represents a&#xa0;substantial healthcare burden.</p> Conclusion <p>The skin cancer burden is increasingly concentrated in older populations. Pooled cancer registry data provide a&#xa0;robust basis for prevention strategies and healthcare planning.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Epidemiologie von Hautkrebs in Deutschland

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月28日

查看全文
  • Christian Wittke,
  • Ron Pritzkuleit,
  • Ahmed Bedir,
  • Bernd Holleczek,
  • Alexander Katalinic

摘要

Background

Skin cancer is among the most common malignancies in Germany. In the context of demographic change, a detailed assessment of incidence, mortality, and survival is essential.

Objective

This article describes recent epidemiological indicators of malignant melanoma and non-melanoma skin cancer based on pooled population-based cancer registry data.

Materials and methods

Pooled data from federal state cancer registries were analyzed. Crude and age-standardized incidence and mortality rates, absolute case numbers, and 5‑year survival (Ederer II) were calculated. National estimates were derived by applying age- and sex-specific pooled rates to the German population.

Results

For melanoma, an average of around 28,000 new cases per year in Germany was calculated for the period 2020–2023. Age-standardized rates changed moderately overall but increased markedly in older age groups, while trends below age 50 were stable or declining. Relative 5‑year survival exceeded 95% but decreased with age. Due to its high incidence, non-melanoma skin cancer represents a substantial healthcare burden.

Conclusion

The skin cancer burden is increasingly concentrated in older populations. Pooled cancer registry data provide a robust basis for prevention strategies and healthcare planning.